AzTrials
AzTrials

StrokeNCT07465744

Evaluation of the Support Program to Enhance Self-management Capacity Among Stroke Survivors

A study testing Support self management program in people with Stroke, run by Pham Ngoc Thach University of Medicine.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The goal of this interventional study is to develop and evaluate a post-stroke patient support program aimed at enhancing patients' ability to self-management after discharge to home. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
What is being tested?
Support self management program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
No sites listed yet
Study dates
1 Apr 2026to 1 Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 18 years or older;
  • Clinically diagnosed with ischemic stroke or intracerebral hemorrhage (first-ever or recurrent episode);
  • Assessed by the treating physician as being clinically stable following the acute phase;
  • Mini-Mental State Examination (MMSE) score > 18;
  • Scheduled for follow-up after discharge at the Neurology Outpatient Clinic or the Neurology Clinic, Department of Outpatient Services, University Medical Center Ho Chi Minh City;
  • Able to speak and read Vietnamese;
Show all 10Show fewer
  • Willing to participate in educational sessions within the health self-management program;
  • Able to use a telephone;
  • Having a family member or caregiver accompanying the patient who is able to recognize changes in the patient's physical and mental condition;
  • Providing informed consent to participate in the study.

Who cannot join

  • Diagnosed with stroke secondary to cerebrovascular pathology related to malignancy;
  • Diagnosed with psychiatric disorders such as depression, schizophrenia, bipolar disorder, or personality disorders.

About this study

The goal of this interventional study is to develop and evaluate a post-stroke patient support program aimed at enhancing patients' ability to self-management after discharge to home. The main question it aim to answer are:

After participating in the support program, do patients show improvements in stroke-related knowledge, independence in activities of daily living, and self-efficacy in managing their health?

Read more

Researchers will compare intervention to control group. The control group receive usual care. The intervention group receive usual care and support self management program to see enhance self-efficacy and recovery.

Participants will:

  • Answer a self-report questionnaire
  • Attend to support self management program during 5 sessions in 5 weeks
Conditions
Stroke
Being tested
Support self management program, Usual care
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Support self management programBehavioural

    Five sessions per five weeks of support self management program included stroke education and action planning; deliver rehabilitation, fall prevention, and problem-solving guidance; review progress and refine weekly action plans; reinforce adherence through follow-up; and summarize outcomes while establishing a continued self-management plan.

  • Usual careOther

    Usual care

Study groups in NCT07465744
Study groupRoleWhat they receive
InterventionExperimentalThe intervention group receive usual care and support self management program
Receives: Behavioral: Support self management program; Other: Usual care
ControlOtherThe control group receive usual care.
Receives: Other: Usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self - Efficacy

    Using Stroke self-efficacy questionnaire (SSEQ). Total score ranging from 0 to 130, which is positive corelation to self-efficacy level.

    Measured: Five weeks after stroke

Secondary outcomes (1)
  1. Stroke self - management behaviors

    The level of independence in activities of daily living (Barthel Index)

    Measured: Five weeks after stroke

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2026
  2. Study start1 Apr 2026 (estimated)
  3. Primary completion1 Oct 2026 (estimated)
  4. Study completion1 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Sequential
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07465744
Sponsor's protocol ID
2820/UMP-BOARD
Status last verified
Mar 2026
First submitted
6 Mar 2026
Last updated
12 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Support self management program in people with Stroke, run by Pham Ngoc Thach University of Medicine.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self - Efficacy (time frame: Five weeks after stroke). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in